Gufic Biosciences Bilan de santé
Santé financière contrôle des critères 5/6
Gufic Biosciences possède un total de capitaux propres de ₹5.7B et une dette totale de ₹2.8B, ce qui porte son ratio d'endettement à 49.4%. Son actif total et son passif total sont ₹11.0B et de ₹5.3B. L'EBIT de Gufic Biosciences est ₹1.3B ce qui fait que son ratio de couverture des intérêts 9. Elle dispose de liquidités et de placements à court terme de ₹194.0M.
Informations clés
49.4%
Ratio d'endettement
₹2.84b
Dette
| Ratio de couverture des intérêts | 9x |
| Argent liquide | ₹193.96m |
| Fonds propres | ₹5.74b |
| Total du passif | ₹5.30b |
| Total des actifs | ₹11.05b |
Mises à jour récentes de la santé financière
Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?
Jun 17
These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well
Sep 02Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet
Feb 11Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet
Nov 13Recent updates
There's Reason For Concern Over Gufic Biosciences Limited's (NSE:GUFICBIO) Massive 26% Price Jump
Nov 07We Think You Should Be Aware Of Some Concerning Factors In Gufic Biosciences' (NSE:GUFICBIO) Earnings
Jun 06Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?
Jun 17These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well
Sep 02Should You Be Adding Gufic Biosciences (NSE:GUFICBIO) To Your Watchlist Today?
May 07Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock
Dec 07This Is The Reason Why We Think Gufic Biosciences Limited's (NSE:GUFICBIO) CEO Might Be Underpaid
Sep 15Is Now The Time To Put Gufic Biosciences (NSE:GUFICBIO) On Your Watchlist?
Aug 12Gufic Biosciences' (NSE:GUFICBIO) Performance Is Even Better Than Its Earnings Suggest
Jun 11If You Like EPS Growth Then Check Out Gufic Biosciences (NSE:GUFICBIO) Before It's Too Late
Mar 19What Percentage Of Gufic Biosciences Limited (NSE:GUFICBIO) Shares Do Insiders Own?
Mar 01Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet
Feb 11Is Gufic Biosciences' (NSE:GUFICBIO) 164% Share Price Increase Well Justified?
Jan 23
Why Gufic Biosciences Limited (NSE:GUFICBIO) Looks Like A Quality Company
Jan 05Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock
Dec 18Here's What Gufic Biosciences Limited's (NSE:GUFICBIO) Shareholder Ownership Structure Looks Like
Dec 01Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet
Nov 13The Gufic Biosciences (NSE:GUFICBIO) Share Price Has Gained 116%, So Why Not Pay It Some Attention?
Oct 19Can Gufic Biosciences Limited's (NSE:GUFICBIO) ROE Continue To Surpass The Industry Average?
Sep 14I Built A List Of Growing Companies And Gufic Biosciences (NSE:GUFICBIO) Made The Cut
Aug 24Investors Appear Satisfied With Gufic Biosciences Limited's (NSE:GUFICBIO) Prospects
Aug 03Earnings Tell The Story For Gufic Biosciences Limited (NSE:GUFICBIO)
Jul 09Analyse de la situation financière
Passif à court terme: Les actifs à court terme de GUFICBIO ( ₹5.8B ) dépassent ses passifs à court terme ( ₹3.5B ).
Passif à long terme: Les actifs à court terme de GUFICBIO ( ₹5.8B ) dépassent ses passifs à long terme ( ₹1.8B ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de GUFICBIO ( 46% ) est considéré comme élevé.
Réduire la dette: Le ratio d'endettement de GUFICBIO a été réduit de 123.8% à 49.4% au cours des 5 dernières années.
Couverture de la dette: La dette de GUFICBIO est bien couverte par le flux de trésorerie opérationnel ( 24.6% ).
Couverture des intérêts: Les paiements d'intérêts de GUFICBIO sur sa dette sont bien couverts par l'EBIT ( 9 x couverture).